Download Files:
Impurity C of Alfacalcidol
SKU
HY-13294-1 mg
Category Reference compound
Tags Metabolic Disease, VD/VDR, Vitamin D Related/Nuclear Receptor
$420 – $1,550
Web ID
– HY-13294
Storage Temperature
– 4°C (Powder, protect from light, stored under nitrogen)
Shipping
– Room Temperature
Applications
– Metabolism-sugar/lipid metabolism
Molecular Formula
– C35H49N3O4
References
– [1]Shiraishi et al (2000) Alfacalcidol inhibits bone resorption and stmulates formation in an ovariectomized rat model of osteoporosis: Distinct actions from estrogen. Journal of Bone and Mineral Research. 15 770.|[2]Ringe JD, Schacht E. et al. Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol. Rheumatol Int. 2004 Jul;24(4):189-97.|[3]Ivarsen P, Povlsen JV, Christensen KL.Effect of alfacalcidol on cardiac function in patients with chronic kidney disease stage 4 and secondary hyperparathyroidism: A pilot study.Scand J Urol Nephrol. 2012 Jun 25.|[4]Rianthavorn P, Pisutikul K, Deekajorndech T, Tepmongkol S, Suphapeetiporn K.Prevention of bone loss in children receiving long-term glucocorticoids with calcium and alfacalcidol or menatetrenone.J Pediatr Endocrinol Metab. 2012;25(3-4):307-12.
CAS Number
– 82266-85-1
Molecular Weight
– 575.78
Compound Purity
– 99.81
SMILES
– O[C@@H]1CC(C2C=C3[C@@](CC[C@@H]4[C@@H](CCCC(C)C)C)([H])[C@]4(C)CCC3N(C(N5C6=CC=CC=C6)=O)N2C5=O)=C(C)[C@@H](O)C1
Clinical Information
– No Development Reported
Research Area
– Metabolic Disease
Solubility
– DMSO : 6.67 mg/mL (ultrasonic;warming;heat to 80°C)
Target
– VD/VDR
Pathway
– Vitamin D Related/Nuclear Receptor
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.